Kymera Therapeutics (KYMR) Insider Trading & Ownership $45.79 -0.06 (-0.13%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$45.79 0.00 (0.00%) As of 07/25/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kymera Therapeutics (NASDAQ:KYMR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage16.01%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$42.80MNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$3.69M Get KYMR Insider Trade Alerts Want to know when executives and insiders are buying or selling Kymera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KYMR Insider Buying and Selling by Quarter Kymera Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/30/2025Bros. Advisors Lp BakerDirectorBuy655,500$44.00$28,842,000.00 6/30/2025Bvf Partners L P/IlDirectorBuy317,167$44.00$13,955,348.00 6/3/2025Elena RidloffDirectorSell12,000$46.10$553,200.00 6/3/2025Jeffrey W. AlbersDirectorSell6,349$49.00$311,101.00 6/3/2025Nello MainolfiCEOSell30,000$49.00$1,470,000.00 3/3/2025Bruce N JacobsCFOSell7,035$30.45$214,215.75 3/3/2025Ellen ChiniaraInsiderSell2,241$30.45$68,238.45 3/3/2025Jeremy G ChadwickCOOSell1,383$30.45$42,112.35 1/6/2025Ellen ChiniaraInsiderSell3,129$41.75$130,635.75 9/17/2024Pamela EspositoDirectorSell13,500$48.28$651,780.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/26/2024Jeffrey W. AlbersDirectorSell5,000$49.10$245,500.00 (Data available from 1/1/2013 forward) KYMR Insider Trading Activity - Frequently Asked Questions Who is on Kymera Therapeutics' Insider Roster? The list of insiders at Kymera Therapeutics includes Bros. Advisors Lp Baker, Bruce Booth, Bruce N Jacobs, Bvf Partners L P/Il, Elena Ridloff, Ellen Chiniara, Jared Gollob, Jeffrey W. Albers, Jeremy G Chadwick, Joanna Horobin, Nello Mainolfi, Pamela Esposito, and Venture Fund X L.P. Atlas. Learn more on insiders at KYMR. What percentage of Kymera Therapeutics stock is owned by insiders? 16.01% of Kymera Therapeutics stock is owned by insiders. Learn more on KYMR's insider holdings. Which Kymera Therapeutics insiders have been buying company stock? The following insiders have purchased KYMR shares in the last 24 months: Bros. Advisors Lp Baker ($28,842,000.00), and Bvf Partners L P/Il ($16,474,313.84). How much insider buying is happening at Kymera Therapeutics? Insiders have purchased a total of 1,189,073 KYMR shares in the last 24 months for a total of $45,316,313.84 bought. Which Kymera Therapeutics insiders have been selling company stock? The following insiders have sold KYMR shares in the last 24 months: Bruce Booth ($28,916,789.09), Bruce N Jacobs ($378,892.99), Elena Ridloff ($553,200.00), Ellen Chiniara ($273,275.30), Jared Gollob ($2,698,135.95), Jeffrey W. Albers ($1,028,335.25), Jeremy G Chadwick ($42,112.35), Joanna Horobin ($280,415.00), Nello Mainolfi ($1,470,000.00), Pamela Esposito ($651,780.00), and Venture Fund X L.P. Atlas ($6,672,891.40). How much insider selling is happening at Kymera Therapeutics? Insiders have sold a total of 1,070,328 Kymera Therapeutics shares in the last 24 months for a total of $42,965,827.33 sold. Kymera Therapeutics Key ExecutivesDr. Bruce L. Booth DPHIL (Age 50)Ph.D., Co-Founder & Independent Chairman Compensation: $75kDr. Nello Mainolfi M.D. (Age 45)Ph.D., Co-Founder, President, CEO & Director Compensation: $1.08MMr. Bruce N. Jacobs CFAChief Financial Officer1 recent tradesDr. Jeremy G. Chadwick Ph.D. (Age 61)Chief Operating Officer Compensation: $883kMs. Ellen V. Chiniara Esq. (Age 65)J.D., Chief Legal Officer & Corporate Secretary Compensation: $640.35kDr. Jared A. Gollob M.D. (Age 59)Chief Medical Officer Compensation: $723.6kMs. Karen WeisbachHead of People & CultureDr. Juliet Williams B.A Ph.D.Head of Research More Insider Trading Tools from MarketBeat Related Companies VTRS Insider Trading BBIO Insider Trading VRNA Insider Trading BPMC Insider Trading ROIV Insider Trading ELAN Insider Trading RVMD Insider Trading GRFS Insider Trading TGTX Insider Trading NUVL Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:KYMR) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredStrait of Hormuz = $100 Oil?Dow Drops 540 Points, Oil Soars Middle East conflict sends markets plunging, oil jumping 8.5%. Investors fl...The Oxford Club | SponsoredThe AI Chip Trade is OUT. This is in…Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kymera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kymera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KYMR Stock Alerts